Online Booking

Dr David Long

GOW
Sport & Exercise Medicine Registrar
|
Geelong Campus, Olympic Park Campus, Warrnambool Campus
Bachelor of Science (Hons), Bachelor of Medicine and Bachelor of Surgery from Melbourne University

Bio

Dr David Long completed his medical degree at the University of Melbourne in 2006. He spent 8 years working in the field of critical care and emergency medicine with a special interest in trauma and continues to work part time in this capacity. He has also worked in the field of sports medicine for the past five years providing medical coverage for elite team sports including VFL and AFL clubs and for the Super 15 Rugby Union.

In 2015 David commenced his specialist training in sports and exercise medicine at Olympic Park Sports Medicine Clinic. His special interests include acute injury management and the biomechanical basis of recurrent soft tissue injury in all sports. His past personal sporting involvements include gymnastics, AFL, basketball, tennis and alpine skiing. He is also a keen musician having studied a variety of instruments for over 30 years and would be happy seeing musicians with musculoskeletal or other medical issues affecting their performance.

David also has a background in research having completed a Bachelor of Science with honours in anatomy and neuroscience and worked in neuroscience and diabetes research for 5 years.

Share this:
Tweet about this on TwitterShare on FacebookShare on Google+Email this to someone

Qualifications

2006
Bachelor of Medicine & Bachelor of Surgery (MBBS), University of Melbourne
1999
Bachelor of Science (Honours) (BSc(Hons)), University of Melbourne

Career Highlights / Affiliations / Associations

  • Medical Officer – Carlton Blues AFL Football Club (2014-Present)
  • Match Day Doctor – Melbourne Rebels, Super 15 Rugby (2014-Present)
  • Chief Medical Officer – Northern Blues VFL Football Club (2014-Present)
  • Medical Officer – St Kilda AFL Football Club (2012-2014)
  • Chief Medical Officer – Sandringham VFL Football Club (2011-2014)
Share this:
Tweet about this on TwitterShare on FacebookShare on Google+Email this to someone

Research / Publications

Coughlan MT, Thallas-Bonke V, Pete J, Long DM, Gasser A, Tong DC, Arnstein M, Thorpe SR, Cooper ME, Forbes JM. Combination therapy with the advanced glycation end product cross-link breaker, alagebrium, and angiotensin converting enzyme inhibitors in diabetes: synergy or redundancy? Endocrinology. 2007 Feb;148(2):886-95.
Coughlan MT, Thallas-Bonke V, Pete J, Long DM, Gasser A, Tong DC, Arnstein M, Thorpe SR, Cooper ME, Forbes JM. Combination therapy with the AGE cross-link breaker, alagebrium and angiotensin converting enzyme inhibitors in diabetes: Synergy or redundancy? Endocrinology. 2006 Nov 16;
Forbes JM, Thorpe SR, Thallas-Bonke V, Pete J, Thomas MC, Deemer ER, Bassal S, El-Osta A, Long DM, Panagiotopoulos S, Jerums G, Osicka TM, Cooper ME. (2005) Modulation of soluble receptor for advanced glycation end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathy. J Am Soc Nephrol. 2005Aug;16(8):2363-72. Epub 2005 Jun 1.
Lee FT, Cao Z, Long DM, Panagiotopoulos S, Jerums G, Cooper ME, Forbes JM. (2004) Interactions between angiotensin II and NF-kappaB-dependent pathways in modulating macrophage infiltration in experimental diabetic nephropathy. J Am Soc Nephrol. 2004 Aug;15(8):2139-51.
Forbes J.M, Soulis T, Thallas V, Panagiotopoulos S, Long D.M., Jerums G, Cooper M.E. (2001) Renoprotective effects of a novel inhibitor of advanced glycation. Diabetologia 2001 44:108-114.

Professional Conference Presentations

  • Long, D.M., Goodwin, A.W. and Wheat, H.E. (2000) SAI mechanoreceptive afferents convey information about force applied tangentially to the fingerpad. Proceedings of the Australian Neuroscience Society, Volume 11, p 213
  • Forbes J.M, Soulis T, Thallas V, Panagiotopoulos S, Long D, Jerums G, Cooper M.E. (2001)  Renoprotective effects of a novel inhibitor of advanced glycation.  IDF, Mexico City,
  • Panagiotopoulos S, Forbes J.M, Soulis T, Thallas V, Long D, Jerums G, Cooper M.E. (2000). ALT 946, A novel inhibitor of advanced glycation, prevents albuminuria in experimental diabetes.  ASN, Toronto,
  • Long, DM (2015) Morton’s Neuroma: A review of current evidence in diagnosis and management. ASCP National Conference
Share this:
Tweet about this on TwitterShare on FacebookShare on Google+Email this to someone

Book Online

Choose a location to book an appointment now

OLYMPIC PARK GEELONG WARNAMBOOL
Campus Key
O
Olympic Park Campus
G
Geelong Campus
W
Warrnambool Campus
Find a Practitioner